Malignant ascites: pathophysiology and treatment Emanuel CavazzoniWalter BugiantellaAnnibale Donini Review Article 31 March 2012 Pages: 1 - 9
Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer Takahiro TsushimaShuichi HironakaKeisei Taku Original Article 22 October 2011 Pages: 10 - 16
Difference in survival and prognostic factors between smokers and never-smokers with advanced non-small-cell lung cancer Shiro TanakaKazuhiro YanagiharaMasanori Fukushima Original Article 10 November 2011 Pages: 17 - 25
The prognostic analysis of clinical breast cancer subtypes among patients with liver metastases from breast cancer Xiao Feng DuanNa Na DongQiang Li Original Article 27 October 2011 Pages: 26 - 32
Caffeine-potentiated chemotherapy for clear cell sarcoma: a report of five cases Michiaki KaritaHiroyuki TsuchiyaHideji Nishida Original Article 01 November 2011 Pages: 33 - 37
Adjuvant therapy with imatinib mesylate after resection of primary high-risk gastrointestinal stromal tumors in Japanese patients Tatsuo KandaToshirou NishidaAtsushi Ohtsu Original Article 23 November 2011 Pages: 38 - 45
Computed tomography fluoroscopy-guided radiofrequency ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas invisible on ultrasonographic images Haruyuki TakakiKoichiro YamakadoKan Takeda Original Article 22 October 2011 Pages: 46 - 53
Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy Tomoya NagaoTakayuki KinoshitaYoshikazu Kagami Original Article 09 November 2011 Pages: 54 - 61
Can docetaxel therapy improve overall survival from primary therapy compared with androgen-deprivation therapy alone in Japanese patients with castration-resistant prostate cancer? A multi-institutional cooperative study Tomoyuki ShimabukuroShigeru SakanoHideyasu Matsuyama Original Article 03 November 2011 Pages: 62 - 67
Randomized controlled study of natural interferon α as adjuvant treatment for stage II or III renal cell carcinoma Shiro HinotsuKoji KawaiHideyuki Akaza Original Article 09 November 2011 Pages: 68 - 74
Transurethral prostate biopsy before radical cystectomy remains clinically relevant for decision-making on urethrectomy in patients with bladder cancer Koji IchiharaHiroshi KitamuraTaiji Tsukamoto Original Article 08 November 2011 Pages: 75 - 80
Third-line sunitinib following sequential use of cytokine therapy and sorafenib in Japanese patients with metastatic renal cell carcinoma Hideaki MiyakeYuji KusudaMasato Fujisawa Original Article 18 November 2011 Pages: 81 - 86
Evaluation of safety, pharmacokinetics, and efficacy of vorinostat, a histone deacetylase inhibitor, in the treatment of gastrointestinal (GI) cancer in a phase I clinical trial Toshihiko DoiTetsuya HamaguchiAtsushi Ohtsu Original Article 11 January 2012 Pages: 87 - 95
Pharmacoethnicity of docetaxel-induced severe neutropenia: integrated analysis of published phase II and III trials Ryoichi YanoAya KonnoMikio Masada Original Article 18 November 2011 Pages: 96 - 104
Cervical stromal involvement can predict survival in advanced endometrial carcinoma: a review of 67 patients Salih TaşkınFırat OrtaçMete Güngör Original Article 18 November 2011 Pages: 105 - 109
Could salvage surgery after chemotherapy have clinical impact on cancer survival of patients with metastatic urothelial carcinoma? Kensuke BekkuTakashi SaikaHiromi Kumon Original Article 18 November 2011 Pages: 110 - 115
Enhanced antitumor effect of lower-dose and longer-term CPT-11 treatment in combination with low-dose celecoxib against neuroblastoma xenografts Setsuko KanekoMichio KanekoTakashi Fukushima Original Article 01 December 2011 Pages: 116 - 125
Docetaxel/irinotecan combination chemotherapy in platinum/taxane-refractory and -resistant ovarian cancer: JGOG/WJGOG Intergroup Study Kimio UshijimaToshiharu KamuraKazunori Ochiai Original Article 30 November 2011 Pages: 126 - 131
Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer Yuko TanabeKenji HashimotoYasuhiro Fujiwara Original Article 22 November 2011 Pages: 132 - 138
Factors associated with the survival of patients with primary small cell carcinoma of the kidney Shen-Yang LeeHsiang-Hao HsuChih-Wei Yang Original Article 06 December 2011 Pages: 139 - 147
Salvage chemotherapy for recurrent or persistent clear cell carcinoma of the ovary: a single-institution experience for a series of 20 patients Kiyoshi YoshinoTakayuki EnomotoTadashi Kimura Original Article 10 December 2011 Pages: 148 - 153
Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma Takahiro KiyosueShintaro KawanoSeiji Nakamura Original Article 15 December 2011 Pages: 154 - 163
Prognostic factors for patients with solitary bone metastasis Manabu HoshiJun TakadaHiroaki Nakamura Original Article 17 December 2011 Pages: 164 - 169
Neoadjuvant and adjuvant chemotherapy with modified mesna, adriamycin, ifosfamide, and dacarbazine (MAID) regimen for adult high-grade non-small round cell soft tissue sarcomas Koichi OguraTakahiro GotoHirotaka Kawano Original Article 17 December 2011 Pages: 170 - 176
Carboplatin–gemcitabine combination chemotherapy upregulates AKR1B10 expression in bladder cancer Yasuhiro HashimotoKengo ImanishiChikara Ohyama Original Article 27 December 2011 Pages: 177 - 182
